ABOUT
Our Members
Board of Directors
Staff
Our Support
Contact Us
Issue Areas
COVID-19
Health Equity, Diversity, & Inclusion
Reducing Health Costs
Health Care Reform
Value
Real-World Evidence
Patient Engagement
FDA Regulations
Medicaid Unwinding Resources
Resources
Member Resources
Fair-Market Value Calculator
Patient Experience Mapping
A Blueprint for Developing Patient-Centered Core Impact Sets (PC-CIS)
Meetings & Events
Newsroom
Letters & Comments
Research Briefs
Job Bank
Education
Real-World Evidence Classroom
Value Classroom
Patient-Focused Medical Product Development Series
Clinical Outcome Assessment Series
Health Literacy Series
Health Care Quality
Webinars
Blog
Membership
Our Members
Standards of Excellence
CAE Approved Provider
Join Us
Accessibility Tools
Toggle navigation
letters & comments
NHC Comments on Methodological Challenges Related to Patient Experience Data
07/03/2023
Read More
NHC Comments on ICER Value Assessment Framework
06/30/2023
Read More
NHC Comments on HPMS Solicitation
06/05/2023
Read More
NHC Comments on Information Collection Request for Drug Price Negotiation by IRA
05/22/2023
Read More
NHC Comments on External Controls Guidance
05/02/2023
Read More
NHC Comments on IRA Guidance Response
04/14/2023
Read More
NHC Comments on Help Committee Pandemic Preparedness RFI
03/29/2023
Read More
NHC Statement for the Record for Energy and Commerce Health Subcommittee Hearing on Transparency
03/28/2023
Read More
Patient Group Letter for Ongoing Engagement on Implementation of Part D Cap and Smoothing Provisions
03/27/2023
Read More
« Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Next »
